The association between lung function and fatal stroke in a community followed for 4 decades

Journal of Epidemiology and Community Health

Volumn 66, Issue 11, 2012, Pages 1030-1036

  Gulsvik, Anne Kristine ^a   Gulsvik, Amund ^b   Skovlund, Eva ^c   Thelle, Dag Steinar ^c   Mowé, Morten ^a   Humerfelt, Sjur ^a   Wyller, Torgeir Bruun ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BASELINE SURVEY; BODY MASS; COHORT ANALYSIS; DIABETES; HEALTH RISK; HYPERTENSION; MORTALITY; RESPIRATORY DISEASE; RISK FACTOR; SMOKING; SOCIOECONOMIC STATUS; STROKE;

ADULT; AGED; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; EPIDEMIOLOGY; EXERCISE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; LUNG; LUNG FUNCTION TEST; MALE; MIDDLE AGED; MORTALITY; NORWAY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; SOCIOECONOMICS; TIME;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CONFOUNDING FACTORS (EPIDEMIOLOGY); EXERCISE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; NORWAY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; SOCIOECONOMIC FACTORS; STROKE; TIME FACTORS;

NORWAY;

EID: 84869097547     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2011-200312     Document Type: Article

References (38)

1. World Health Organization. The Leading Causes of Death. 2004. http://www.who. int/mediacentre/factsheets/fs310/en/index.html (accessed 1 Aug 2010).
2. World Health Organization. Mortality Country Fact Sheet. 2006. http://www.who. int/ whosis/mort/profiles/mort_euro_nor_norway.pdf (accessed 1 Aug 2010).
3. Chowdhuri SM, Crook EDM, Taylor HAJ, et al. Cardiovascular complications of respiratory diseases. Am J Med Sci 2007;334:361e80.
4. Frostad A, Soyseth V, Haldorsen T, et al. Respiratory symptoms and long-term cardiovascular mortality. Respir Med 2007;101:2289e96.
5. Wannamethee SG, Shaper AG, Ebrahim S. Respiratory function and risk of stroke. Stroke 1995;26:2004e10.
6. Hart CL, Hole DJ, Smith GD. Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland. Stroke 2000;31:1893e6.
7. Hozawa A, Billings JL, Shahar E, et al. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest 2006;130:1642e9.
8. Schanen JG, Iribarren C, Shahar E, et al. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax 2005;60:633e8.
9. Onufrak S, Abramson J, Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2007;195:129e37.
10. Strachan DP. Ventilatory function, height, and mortality among lifelong nonsmokers. J Epidemiol Community Health 1992;46:66e70.
11. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952e9.
12. Dow L, Ebrahim S. Commentary: lung function and risk of fatal and non-fatal stroke-The Copenhagen City Heart Study. Int J Epidemiol 2001;30:152e3.
13. Gulsvik A, Humerfelt S, Bakke PS, et al. Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality control and response rates. Clin Respir J 2008;2:10e25.
14. Gulsvik AK, Thelle DS, Mowe M, et al. Increased mortality in the slim elderly. A 42 year follow-up study in a general population. Eur J Epidemiol 2009;24:683e90.
15. Humerfelt S, Gulsvik A, Skjaerven R, et al. Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community. Eur Respir J 1993;6:1095e103.
16. Drew CD, Hughes DT. Characteristics of the vitalograph spirometer. Thorax 1969;24:703e6.
17. Johannessen A, Lehmann S, Omenaas ER, et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006;173:1316e25.
18. Rose GA, Holland W, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964;1:296e300.
19. Fletcher C, Elmes P, Fairbairn A, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2:257e66.
20. Alonso J, Perez P, Saez M, et al. Validity of the occupation as an indicator of social class, according to the British Registrar General classification. Gac Sanit 1997;11:205e13. [English abstract].
21. Technicon Autoanalyzer II. Clinical Method No. 24. Tarrytown, NY: Technicon Instruments, 1972.
22. World Health Organization. Cause of Death Definition. 2010. http://www.who.int/ healthinfo/statistics/mortdata/en/index html (accessed 1 Aug 2010).
23. Eurostat. European Shortlist for Causes of Death. 1998. http://ec.europa.eu/eurostat/ramon/nomenclatures/index.cfm?TargetUrl=LST_NOM_DTL&StrNom=COD_1998 (accessed 1 Aug 2010).
24. Gulsvik AK, Gulsvik A, Svendsen E, et al. Diagnostic validity of fatal cerebral strokes and Coronary deaths in mortality statistics: an autopsy study. Eur J Epidemiol 2011;26:221e8.
25. Rothman KJ. Modern Epidemiology. 4th Printing edn. Boston, Toronto, USA: Little, Brown and Company, 1986:125e6.
26. Harmsen P, Lappas G, Rosengren A, et al. Long-term risk factors for stroke: twentyeight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke 2006;37:1663e7.
27. Suwa T, Hogg JC, Quinlan KB, et al. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002;39:935e42.
28. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109(21 Suppl 1):II2e10.
29. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999;30:841e50.
30. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax 2004;59:574e80.
31. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999;54:1119e38.
32. Camp PG, O'Donnell DE, Postma DS. Chronic obstructive pulmonary disease in men and women: myths and reality. Proc Am Thorac Soc 2009;6:535e8.
33. Bjartveit K, Foss OP, Gjervig T. The cardiovascular disease study in Norwegian counties. Results from first screening. Acta Med Scand Suppl 1983;675:1e184.
34. Truelsen T, Prescott E, Lange P, et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001;30:145e51.
35. Tamagawa E, van Eeden SF. Impaired lung function and risk for stroke: role of the systemic inflammation response? Chest 2006;130:1631e3.
36. Mork T. A comparative study of respiratory disease in England & Wales and Norway. Acta Med Scand 1962;172:1e100.
37. Dyken ME, Im KB. Obstructive sleep apnea and stroke. Chest 2009;136: 1668e77.
38. Haheim LL, Holme I, Hjermann I, et al. Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke 1993;24:1484-9.